CUA Educational Content

Case Studies in Prostate Cancer: Patient Pathways for Genetic Testing and Treatment

EDITORIAL COMMITTEE: Michael Kolinsky and Franciso Vera-Badillo

By the end of this program, participants will be able to:

  • Review treatment sequencing along patient pathway (prostate cancer patient cases)
  • Discuss practical considerations for tumor testing (who, when and how to test)
  • Target DNA repair defects in prostate cancer and the role of PARP inhibitors


This program has received financial support from AstraZeneca and Merck in the form of an educational grant.